期刊
HUMAN MUTATION
卷 39, 期 2, 页码 237-254出版社
WILEY
DOI: 10.1002/humu.23366
关键词
Fanconi anemia; FANCA; functional assay; pathogenic mutations; recessive disorder
资金
- Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health
- National Heart Lung and Blood Institute, NIH [NIH RO1HL120922]
- National Center for Advancing Translational Sciences (NCATS), NIH [UL1TR001866]
- NIH Clinical and Translational Science Award (CTSA)
- Howard Hughes Faculty Scholar Grant
Fanconi anemia (FA) is a rare recessive DNA repair deficiency resulting from mutations in one of at least 22 genes. Two-thirds of FA families harbor mutations in FANCA. To genotype patients in the International Fanconi Anemia Registry (IFAR) we employed multiple methodologies, screening 216 families for FANCA mutations. We describe identification of 57 large deletions and 261 sequence variants, in 159 families. All but seven families harbored distinct combinations of two mutations demonstrating high heterogeneity. Pathogenicity of the 18 novel missense variants was analyzed functionally by determining the ability of the mutant cDNA to improve the survival of a FANCA-null cell line when treated with MMC. Overexpressed pathogenic missense variants were found to reside in the cytoplasm, and nonpathogenic in the nucleus. RNA analysis demonstrated that two variants (c.522G>C and c.1565A>G), predicted to encode missense variants, which were determined to be nonpathogenic by a functional assay, caused skipping of exons 5 and 16, respectively, and are most likely pathogenic. We report 48 novel FANCA sequence variants. Defining both variants in a large patient cohort is a major step toward cataloging all FANCA variants, and permitting studies of genotype-phenotype correlations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据